About this trial
The purpose of this study is to compare the uptake of \[18F\]FTC-146 in healthy volunteers to that of individuals suffering from chronic pain with Spinal or Peripheral Nerve Origin.
Primary Objectives:
A) To quantify the bio-distribution of \[18F\] FTC-146 uptake in subjects with Spinal or Peripheral Nerve Origin pain and compare it with healthy controls.
B) To determine whether painful schwannomas can be differentiated from non-painful schwannomas based on imaging.
Secondary Objectives:
A) To assess the reproducibility of \[18F\]FTC-146 PET imaging within the same healthy volunteer subjects using Test-Retest analysis.
B) To investigate whether post-treatment \[18F\]FTC-146 uptake differs from pre-treatment uptake and correlate the imaging with subject reported pain level after treatment
Eligibility criteria
Qualifiers
Healthy Volunteers
Pain Subjects
At least 18 years old.
Chronic Pain is of Spinal or Peripheral Nerve Origin
Disqualifiers
Healthy Volunteers
Any chronic Pain
Use of pain medication.
MRI incompatibility.
Trial design
Treatments tested in this trial
- [18F]FTC-146